{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:49:38Z","timestamp":1788263378693,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.imbio.2026.153193","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:35:53Z","timestamp":1779464153000},"page":"153193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of anti-DFS70 positivity with disease activity in systemic lupus erythematosus, Sj\u00f6gren's syndrome, and systemic sclerosis: a cross sectional study"],"prefix":"10.1016","volume":"231","author":[{"given":"Esra Dilsat","family":"Imrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev","family":"Cetin Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.imbio.2026.153193_bb0005","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/annrheumdis-2017-eular.4008","article-title":"Detection of anti-DFS70 antibodies by indirect immunofluorescence (IIF) on novel HEP-2\/DFS70-KO substrate for discriminating antinuclear antibodies (ANA)-positive healthy individuals (HI) and patients with systemic lupus erythematosus (SLE)","volume":"76","author":"Aleksandrova","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imbio.2026.153193_bb0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0961203320969976","article-title":"Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice","volume":"30","author":"Aljadeff","year":"2021","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.imbio.2026.153193_bb0015","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153193_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030132","article-title":"Expression of the stress response oncoprotein LEDGF\/p75 in human cancer: a study of 21 tumor types","volume":"7","author":"Basu","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.imbio.2026.153193_bb0025","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41584-020-00522-w","article-title":"Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases","volume":"16","author":"Bossuyt","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.imbio.2026.153193_bb0030","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2013-205171","article-title":"Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort","volume":"74","author":"Bruce","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imbio.2026.153193_bb0035","article-title":"Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.imbio.2026.153193_bb0040","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/0961203317692437","article-title":"The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients","volume":"26","author":"Choi","year":"2017","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.imbio.2026.153193_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12016-016-8564-5","article-title":"The clinical relevance of anti-DFS70 autoantibodies","volume":"52","author":"Conrad","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153193_bb0050","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/art.20095","article-title":"Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us?","volume":"50","author":"Ganapathy","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imbio.2026.153193_bb0055","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.imbio.2026.153193_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024556","article-title":"Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan","volume":"100","author":"Hayashi","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.imbio.2026.153193_bb0065","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imbio.2026.153193_bb0070","doi-asserted-by":"crossref","first-page":"1115548","DOI":"10.3389\/fimmu.2023.1115548","article-title":"Isolated anti-Ro52 identifies a severe subset of Sj\u00f6gren\u2019s syndrome patients","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153193_bb0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/ker368","article-title":"Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort","volume":"51","author":"L\u00f3pez","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imbio.2026.153193_bb0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1749-6632.2009.05127.x","article-title":"Epitope specificity and significance in systemic autoimmune diseases","volume":"1183","author":"Mahler","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imbio.2026.153193_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/494356","article-title":"The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases","volume":"2012","author":"Mahler","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153193_bb0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.30084","article-title":"Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases","volume":"63","author":"Mariz","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.imbio.2026.153193_bb0095","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/ard.2009.127100","article-title":"ANA screening: an old test with new recommendations","volume":"69","author":"Meroni","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imbio.2026.153193_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0961203307086311","article-title":"High concomitance of disease marker autoantibodies in anti-DFS70\/LEDGF autoantibody-positive patients with autoimmune rheumatic disease","volume":"17","author":"Muro","year":"2008","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.imbio.2026.153193_bb0105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/25785826.2021.1919342","article-title":"Clinical manifestations in anti-Ro52\/SS-A antibody-seropositive patients with Sj\u00f6gren\u2019s syndrome","volume":"44","author":"Nakamura","year":"2021","journal-title":"Immunol. Med."},{"issue":"3","key":"10.1016\/j.imbio.2026.153193_bb0110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0022-5347(17)35023-1","article-title":"Autoantibodies in interstitial cystitis","volume":"151","author":"Ochs","year":"1994","journal-title":"J. Urol."},{"issue":"6 Pt 1","key":"10.1016\/j.imbio.2026.153193_bb0115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1067\/mai.2000.107039","article-title":"Autoantibodies to DFS 70 kd\/transcription coactivator p75 in atopic dermatitis and other conditions","volume":"105","author":"Ochs","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2026.153193_bb0120","first-page":"686","article-title":"Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren\u2019s syndrome","volume":"30","author":"Retamozo","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.imbio.2026.153193_bb0125","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imbio.2026.153193_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.imbio.2026.153193_bb0135","first-page":"1516","article-title":"The burden of illness of the organ manifestations of systemic sclerosis: a pragmatic, targeted review","volume":"43","author":"Smith","year":"2025","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153193_bb0140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","article-title":"The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","volume":"76","author":"Valentini","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imbio.2026.153193_bb0145","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.20096","article-title":"Anti-DFS70 antibodies in 597 healthy hospital workers","volume":"50","author":"Watanabe","year":"2004","journal-title":"Arthritis Rheum."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:43:30Z","timestamp":1782463410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0171298526000392"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153193","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of anti-DFS70 positivity with disease activity in systemic lupus erythematosus, Sj\u00f6gren's syndrome, and systemic sclerosis: a cross sectional study","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153193"}}